Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75,031 | 44 | 68.8% |
| Travel and Lodging | $22,659 | 112 | 20.8% |
| Food and Beverage | $8,650 | 334 | 7.9% |
| Consulting Fee | $2,750 | 1 | 2.5% |
| Education | $23.20 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $102,377 | 203 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $983.31 | 52 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $778.75 | 39 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $582.11 | 29 | $0 (2024) |
| Ironshore Pharmaceuticals Inc. | $490.79 | 6 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $462.43 | 17 | $0 (2024) |
| Novo Nordisk Inc | $443.84 | 4 | $0 (2022) |
| Shire North American Group Inc | $332.16 | 18 | $0 (2018) |
| ARBOR PHARMACEUTICALS, INC. | $288.42 | 21 | $0 (2019) |
| Lundbeck LLC | $266.62 | 22 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,076 | 12 | Vanda Pharmaceuticals Inc. ($249.97) |
| 2022 | $793.24 | 8 | Novo Nordisk Inc ($443.84) |
| 2021 | $88.75 | 5 | AbbVie Inc. ($52.86) |
| 2020 | $125.25 | 1 | Ironshore Pharmaceuticals Inc. ($125.25) |
| 2019 | $4,536 | 37 | Merck Sharp & Dohme Corporation ($3,692) |
| 2018 | $40,422 | 193 | Merck Sharp & Dohme Corporation ($38,410) |
| 2017 | $62,072 | 238 | Merck Sharp & Dohme Corporation ($60,275) |
All Payment Transactions
494 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $111.12 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $124.97 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $149.97 | General |
| Category: Neuroscience | ||||||
| 08/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 07/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Education | In-kind items and services | $12.15 | General |
| Category: PSYCHIATRY | ||||||
| 07/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $122.95 | General |
| Category: Obesity | ||||||
| 06/02/2024 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $154.86 | General |
| 05/02/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: OUD | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $88.23 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: PSYCHIATRY | ||||||
| 11/16/2022 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $145.65 | General |
| Category: Obesity | ||||||
| 08/17/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $111.38 | General |
| Category: CNS | ||||||
| 08/10/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $112.78 | General |
| Category: PSYCHIATRY | ||||||
| 07/21/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $112.28 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 06/30/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $93.84 | General |
| 06/23/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $105.74 | General |
| Category: Obesity | ||||||
| 05/05/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $98.61 | General |
| Category: Obesity | ||||||
| 05/05/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 10/29/2021 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 10/13/2021 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: ANTI-ANXIETY | ||||||
| 06/11/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 46 | 141 | $11,664 | $7,312 |
| 2022 | 3 | 57 | 177 | $15,418 | $11,220 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 115 | $10,755 | $6,764 | 62.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 14 | 26 | $909.22 | $548.40 | 60.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 134 | $11,991 | $8,792 | 73.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 18 | $2,553 | $1,793 | 70.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 15 | 25 | $874.25 | $635.14 | 72.6% |
About Dr. Denise Curry, M.D
Dr. Denise Curry, M.D is a Psychiatry healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891786406.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Denise Curry, M.D has received a total of $109,113 in payments from pharmaceutical and medical device companies, with $1,076 received in 2024. These payments were reported across 494 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($75,031).
As a Medicare-enrolled provider, Curry has provided services to 103 Medicare beneficiaries, totaling 318 services with total Medicare billing of $18,532. Data is available for 2 years (2022–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Saint Louis, MO
- Active Since 11/02/2005
- Last Updated 01/08/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891786406
Products in Payments
- BELSOMRA (Drug) $98,679
- REXULTI (Drug) $948.46
- LATUDA (Drug) $778.75
- INVEGA SUSTENNA (Drug) $307.17
- CAPLYTA (Drug) $272.24
- JORNAY PM (Drug) $262.49
- FANAPT (Drug) $249.97
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $228.30
- Fanapt (Drug) $212.46
- MYDAYIS (Drug) $210.73
- VRAYLAR (Drug) $205.25
- Saxenda (Drug) $204.35
- Evekeo (Drug) $200.43
- AUSTEDO (Drug) $169.36
- Trintellix (Drug) $155.39
- CHANTIX (Drug) $151.16
- Wegovy (Drug) $145.65
- SPRAVATO (Drug) $145.22
- ABILIFY MAINTENA (Drug) $142.82
- INVEGA TRINZA (Drug) $129.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saint Louis
Dr. Mohd Malik, M.d, M.D
Psychiatry — Payments: $1.8M
Adam Sky, Md, MD
Psychiatry — Payments: $1.4M
Dr. Junaid Syed, M.d, M.D
Psychiatry — Payments: $1.1M
Dr. Michael Stotler, Md, MD
Psychiatry — Payments: $299,451
Dr. Naji Chaaya Salloum, M.d, M.D
Psychiatry — Payments: $236,374
Dr. Devnandini Rastogi, Md, MD
Psychiatry — Payments: $230,240